Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 6Overweight 2Obesity 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunctions, Psychological 1Ovarian Neoplasms 1Depressive Disorder, Major 1

Interventions

Methods 3Trastuzumab 2Radiotherapy 2Early Intervention, Educational 2Behavior Therapy 2tivozanib 1tipifarnib 1nanocis 1entinostat 1atezolizumab 1Technetium-99 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Interviews as Topic 1Interleukin-12 Subunit p35 1Interleukin-12 1Infracyanine green 1Indocyanine Green 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Hysterectomy 1Gene Rearrangement 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Bupropion × Breast × Clear all
NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NRG Oncology

Phase 2 Completed
230 enrolled 24 charts
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡